Taltz

(ixekizumab)
taltz 80 MG in 1 ML Auto-Injectortaltz 80 MG in 1 ML Prefilled Syringe
NO BOXED WARNING

Dosage & administration

Administer by subcutaneous injection.

Adult Plaque Psoriasis

Pediatric Plaque Psoriasis


Psoriatic Arthritis


Ankylosing Spondylitis


Non-radiographic Axial Spondyloarthritis


drug label

Taltz prescribing information

prior authorization

Taltz prior authorization resources

Most recent Taltz prior authorization forms

View By Payer
Verified: Feb 28, 2024Anthem Amerigroup - Taltz Prior Authorization Form Texas, Pennsylvania
Verified: Feb 07, 2024Kaiser Foundation Health Plan - Chronic High-Dose Opioid Therapy Prior Authorization Form Washington
Verified: Feb 01, 2024Highmark BCBS Northeastern NY - Medicare Prescription Drug Medication Request Form
Verified: Feb 01, 2024Highmark BCBS Northeastern NY - Short Acting Opioid Prior Authorization Form
Verified: Feb 01, 2024Highmark BCBS Western NY - Specialty Drug Prior Authorization Form

Most recent state uniform prior authorization forms

Verified: Feb 27, 2024Arizona - Uniform Prior Authorization Form
Verified: Feb 27, 2024Colorado - Uniform Prior Authorization Form
Verified: Feb 27, 2024Hawaii - Uniform Prior Authorization Form
Verified: Feb 27, 2024Illinois - Uniform Prior Authorization Form
Verified: Feb 27, 2024Indiana - Uniform Prior Authorization Form
Verified: Feb 27, 2024Louisiana - Uniform Prior Authorization Form
Verified: Feb 27, 2024Michigan - Uniform Prior Authorization Form
Verified: Feb 27, 2024Minnesota - Uniform Prior Authorization Form
Verified: Feb 27, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Feb 27, 2024New Mexico - Uniform Prior Authorization Form
Verified: Feb 27, 2024Oregon - Uniform Prior Authorization Form
Verified: Feb 27, 2024Texas - Uniform Prior Authorization Form
Complete Letter of Medical Necessity
Coverage Authorization Request
Coverage Authorization Appeals
Letter of Medical Necessity - Taltz Loading Dose
Prior Authorization Resource Guide
Letter of Medical Necessity - Taltz Loading Dose (Editable)
Learn More

Benefits investigation

Adult Dermatology - Taltz Together Enrollment & Prescription Form
Pediatric Dermatology - Taltz Together Enrollment & Prescription Form
Adult Rheumatology - Taltz Together Enrollment & Prescription Form
Learn More

pharmacy

Taltz preferred pharmacy

Pharmacy List

Financial Assistance

Financial Assistance Programs

Taltz retails for $6,586 per dose without insurance or financial assistance.Depending on your patient's insurance situation and other eligibility criteria, they may be able to get Taltz for significantly less. Review the program information below to determine what program can offer your patient the most benefits.
Patient Assistance Program28 days supply for as low as $5
Available for
commercial
Program Details
  • Program Expires 12/31/2024
  • $9100 Annual Cap
Forms
Adult Dermatology - Taltz Together Enrollment & Prescription Form
Pediatric Dermatology - Taltz Together Enrollment & Prescription Form
Adult Rheumatology - Taltz Together Enrollment & Prescription Form
Enroll in Patient Savings Program
Foundation ProgramFirst dose for $0
Available for
medicare
uninsured
Eligibility requirements
  • Uninsured
  • Medicare Part D
  • Household annual adjusted gross income <= 500% FPL.
Forms
Lilly Cares Patient Assistance Program Eligibility Check
Digital Enrollment - Lilly Patient Support Provider Portal
Lilly Cares Enrollment Form - Spanish
Lilly Cares Enrollment Form - English
Lilly Cares - Online Enrollment

PubMed™ | Taltz

Taltz PubMed™ News

patient education

Taltz patient education

Getting started on Taltz

Instructions For Use: Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Psoriatic Arthritis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Ankylosing Spondylitis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Non-radiographic Axial Spondyloarthritis (nr-axSpA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

About Taltz: Plaque Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Stories: Plaque Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Before & After: Plaque Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Genital Plaque Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Taltz (Pediatric): Plaque Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Before & After (Pediatric): Plaque Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Taltz: Psoriatic Arthritis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Stories: Psoriatic Arthritis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Taltz: Ankylosing Spondylitis (AS) & Non-radiographic Axial Spondyloarthritis (nr-axSpA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Taltz Cost Information
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Taltz Together Program
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

App Download
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Sharps Disposal
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Taltz FAQs

What is the Pregnancy Exposure Registry?It is a registry that monitors pregnancy outcomes in women exposed to TALTZ during pregnancy.
How can pregnant women enroll in the TALTZ Pregnancy Registry?Pregnant women exposed to TALTZ can enroll in the registry by calling 1-800-284-1695. Contact information for the registry is also available on https://www.taltz.com.
What is the risk associated with TALTZ use in pregnant women?Available data from the published literature and the pharmacovigilance database with TALTZ use in pregnant women are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes.
Is there a risk of harm to the developing fetus with TALTZ use in pregnant women?An embryofetal development study conducted in pregnant monkeys during organogenesis at doses up to 19 times the maximum recommended human dose (MRHD) revealed no evidence of harm to the developing fetus. When dosing was continued until parturition, neonatal deaths were observed at 1.9 times the MRHD. However, the clinical significance of these nonclinical findings is unknown.
What is the background risk of major birth defects and miscarriage in the U.S. general population?The estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies in the U.S. general population is 2 to 4% and 15 to 20%, respectively.
Is TALTZ present in human milk and what are its effects on breastfed infants?There are no available data on the presence of ixekizumab (TALTZ) in human milk, the effects on the breastfed infant, or the effects on milk production. However, ixekizumab was detected in the milk of lactating cynomolgus monkeys. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for TALTZ and any potential adverse effects on the breastfed infant from TALTZ or from the underlying maternal condition.
Is TALTZ safe and effective for use in pediatric patients?TALTZ is approved for use in pediatric patients aged 6-18 years with moderate-to-severe plaque psoriasis. Its safety and effectiveness have not been established in other pediatric indications or in patients less than 6 years of age.
FAQ Data Source